Chemed EBITDA 2010-2024 | CHE

Chemed EBITDA for the quarter ending September 30, 2024 was $0.104B, a 22.29% increase year-over-year.

  • Chemed 2023 EBITDA was 0.402B, a 0.25% decline from 2022.
  • Chemed 2022 EBITDA was 0.403B, a 0.15% increase from 2021.
  • Chemed 2021 EBITDA was 0.402B, a 9.89% decline from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Chemed EBITDA 2010-2024 | CHE

  • Chemed 2023 EBITDA was 0.402B, a 0.25% decline from 2022.
  • Chemed 2022 EBITDA was 0.403B, a 0.15% increase from 2021.
  • Chemed 2021 EBITDA was 0.402B, a 9.89% decline from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Fresenius SE (FSNUY)$20.6B
Quest Diagnostics (DGX)$17.4B
DaVita (DVA)$12.3B
Encompass Health (EHC)$10.4B
Elanco Animal Health (ELAN)$7.2B
RadNet (RDNT)$5.3B
Option Care Health (OPCH)$3.9B
Amedisys (AMED)$3.2B
LifeStance Health (LFST)$2.9B
Astrana Health (ASTH)$2.9B
Addus HomeCare (ADUS)$2.3B
U.S Physical Therapy (USPH)$1.4B
Pennant (PNTG)$1.1B
Aveanna Healthcare Holdings (AVAH)$1.1B
Atai Life Sciences (ATAI)$227M
Daxor (DXR)$45M
MEDIROM Healthcare Technologies (MRM)$14M
Psychemedics (PMD)$14M
ATI Physical Therapy (ATIP)$13M
Ontrak (OTRK)$8M
IMAC Holdings (BACK)$1M